Clinical Trials Consortium.
CTC Background
At the 2017 MICYRN Strategic Retreat and following the merging of MICYRN and CCCHR (The Council for Canadian Child Health Research), there was a consensus that the organization should prioritize its activities with its primary objective being to develop a collaborative national infrastructure to support clinical investigations, with an emphasis on multi-centre clinical trials. The ultimate goal of this consortium is to enhance Canadian child health through increased access to high-quality clinical trials supported by an efficient, safe, and family-centered national infrastructure. Contributions to the national infrastructure at the local site level and broadly encouraging each site to invest in this initiative to enable the development of key deliverables will be imperative if this is to be successful at the national level.
Mandate
The Clinical Trials Consortium (CTC) will prioritize areas of opportunity and develop scientific and operational directions and initiatives. It will engage individuals who have responsibility for overseeing clinical research operations or who are invested in developing clinical research at their member-affiliated MICYRN research organizations across the country.
Increased communication with MICYRN member research organizations will better support multisite projects and investigator teams, and help identify common processes that could benefit from being harmonized across institutions through the development of tactical approaches to realize shared efficiencies.
The CTC will also identify key areas where setting best practices could enhance the quality and outcome of research (i.e., data management, biobanking); and determine means by which to enact best practices. In addition, it will provide input into MICYRN performance metrics and return on investment for MICYRN. Finally, the group will establish and build on opportunities to generate interest in trials from industry and forge international relationships to improve the situation for clinical trials at home and beyond.
Consortium Members
Click here for full member bios.
Anthony Chan | McMaster University |
Ashton Chugh | ACHRI |
Brandy Wicklow | CHRIM |
Bernadette Druken | Janeway Pediatric Research Unit |
Bruno Piedboeuf | Université Laval |
Darryl Adamko | University of Saskatchewan |
Dory Sample | WCHRI |
Entela Zaffino | SickKids |
Evdokia Anagnostou | Bloorview Research Institute |
Frederic Dallaire | Université de Sherbrooke |
Geneviève Legault | Université de Sherbrooke |
Jagdeep Walia | Queen's University |
Jason Berman | CHEO |
Jennifer Claydon | BCCHR |
Jennilea Courtney | CHEO |
Julia Upton | SickKids |
Kathleen Leadon | IWK Health Centre |
Lauren Kelly | CHRIM |
Lindsay Akrong | McMaster University |
Lise Bourrier | CHRIM |
Lonnie Zwaigenbaum | WCHRI |
Megan Stewart | Bloorview Research Institute |
Michael Esser | ACHRI |
Michael Rieder | Western University |
Nathalie Bureau | CHU Sainte-Justine |
Nicole Chabot | Université Laval |
Patti Li | McGill University |
Paul Moorehead | Janeway Pediatric Research Unit |
Quynh Doan | BCCHR |
Soren Gantt | CHU Sainte-Justine |
Steven Beyea | IWK Health Centre |
Tanya Voth | WCHRI |
Tova Dybvig | University of Saskatchewan |
Clinical Trial Consortium Documents
Please contact your organization’s representative (above) for access to archived meeting notes and administrative files.